• Explore /
  • Poster
  • / Phase II study of S-1 on alternate days combined with bevacizumab in elderly patients (aged ≥75 years) with metastatic colorectal cancer (mCRC).

Phase II study of S-1 on alternate days combined with bevacizumab in elderly patients (aged ≥75 years) with metastatic colorectal cancer (mCRC).

Abstract Poster

Authors

null

Tetsuya Eto

Tsuchiura Kyodo General Hospital, Tsuchiura, Japan

Tetsuya Eto , Toshikazu Moriwaki , Hiroyasu Ishida , Shinji Endo , Yoshiyuki Yamamoto , Hidekazu Kuramochi , Mikio Sato , Akihito Tsuji , Yoshiaki Bando , Shunju Indou , Mitsuo Shimada , Kenji Amagai , Masamitsu Morimoto , Kazuma Kobayashi , Tomohiro Nishina , Ichinosuke Hyodo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

UMIN000010402

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr 750)

DOI

10.1200/JCO.2018.36.4_suppl.750

Abstract #

750

Poster Bd #

J16

Abstract Disclosures

Similar Posters

First Author: Akihito Tsuji

First Author: Eiji Oki

First Author: Hideaki Bando

First Author: Zev A. Wainberg